Evelo Biosciences Inc (EVLO)

$0.00 0.00 (N/A)
Market Cap 9,000.00
Revenue (ttm) 0.00
Net Income (ttm) -114.53M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio -1.27
Volume 3,000
Avg Vol 9,436
Day's Range N/A - N/A
Shares Out 18.98M
Stochastic %K 12%
Beta 0.74
Analysts Strong Buy
Price Target $10.00

Company Profile

Evelo Biosciences, Inc., a clinical-stage biotechnology company, focuses on discovering and developing oral medicines that act on immune cells in the small intestine with systemic effects. It is developing EDP1815, a whole-microbe product candidate, which has completed a Phase 2 trial for the treatment of psoriais; and is in Phase 2 clinical trial for the treatment of atopic dermatitis. The company is also developing EDP1867, a non-live pharmaceutical preparation for single strain of Veillonella...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 577 0300
Address:
620 Memorial Drive, 5th Floor, Cambridge, United States
NVDAMillionaire
NVDAMillionaire Mar. 26 at 1:40 AM
$EVLO Interesting biotech play. SINTAX platform looks promising but recent clinical failures raise red flags. Watching closely for strategic alternatives or potential partnership. Might be a speculative entry for risk-tolerant investors. standout article: https://beyondspx.com/article/evelo-biosciences-inc-evlo-exploring-the-potential-of-sintax-medicines
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 17 at 5:26 PM
$EVLO Evelo Biosciences, Inc. (NASDAQ:EVLO): Navigating the Challenges of a Development-Stage Biotech https://beyondspx.com/article/evelo-biosciences-inc-evlo-navigating-the-challenges-of-developing-a-novel-therapeutic-approach
0 · Reply
NVDAMillionaire
NVDAMillionaire Dec. 5 at 4:28 AM
$EVLO Evelo Biosciences, Inc. (EVLO): Navigating the Challenges of Developing a Novel Therapeutic Approach https://beyondspx.com/article/evelo-biosciences-inc-evlo-navigating-the-challenges-of-developing-a-novel-therapeutic-approach
0 · Reply
ganta7
ganta7 Nov. 7 at 3:49 PM
$EVLO Nancy we have the cream for wrinkle skin Lfg
0 · Reply
GreenSky_
GreenSky_ Aug. 6 at 12:06 PM
$MCRB Nestlé knows the remaining pipeline is too risky to acquire the whole company, it's likely to fail. MCRB was founded by Flagship Pioneering so be careful here, this may end up like $EVLO and $KLDO (failed Flagship Pioneering's microbiome companies).
0 · Reply
bdog_stayloyal
bdog_stayloyal Apr. 1 at 2:45 PM
$EVLO I will be very happy if I see this hit $0.07 today.
0 · Reply
sogenerous
sogenerous Feb. 26 at 3:49 PM
$MCRB I am watching this as a turnaround play $EVLO $KLDO went bankrupt in space they are last one left - I think this space has potential despite many setbacks. @Monkey_Banana_Genius Wonder if nestle buys them out, the amount of research in microbiome has exploded last 5 years . Might get 10k and leave it
1 · Reply
Tolon
Tolon Jan. 24 at 6:19 PM
$EVLO What will happen on the 26th to this company?
0 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Dec. 28 at 5:54 PM
$EVLO Hey shortie smile for the camera
0 · Reply
Aamadmi
Aamadmi Dec. 21 at 4:29 PM
$EVLO $MCOM $SMFL Looks like Miami is stubborn in SMFL. Volume in all three can bring good Christmas. SMFL volume is insane
0 · Reply
Latest News on EVLO
No data available.
NVDAMillionaire
NVDAMillionaire Mar. 26 at 1:40 AM
$EVLO Interesting biotech play. SINTAX platform looks promising but recent clinical failures raise red flags. Watching closely for strategic alternatives or potential partnership. Might be a speculative entry for risk-tolerant investors. standout article: https://beyondspx.com/article/evelo-biosciences-inc-evlo-exploring-the-potential-of-sintax-medicines
0 · Reply
NVDAMillionaire
NVDAMillionaire Jan. 17 at 5:26 PM
$EVLO Evelo Biosciences, Inc. (NASDAQ:EVLO): Navigating the Challenges of a Development-Stage Biotech https://beyondspx.com/article/evelo-biosciences-inc-evlo-navigating-the-challenges-of-developing-a-novel-therapeutic-approach
0 · Reply
NVDAMillionaire
NVDAMillionaire Dec. 5 at 4:28 AM
$EVLO Evelo Biosciences, Inc. (EVLO): Navigating the Challenges of Developing a Novel Therapeutic Approach https://beyondspx.com/article/evelo-biosciences-inc-evlo-navigating-the-challenges-of-developing-a-novel-therapeutic-approach
0 · Reply
ganta7
ganta7 Nov. 7 at 3:49 PM
$EVLO Nancy we have the cream for wrinkle skin Lfg
0 · Reply
GreenSky_
GreenSky_ Aug. 6 at 12:06 PM
$MCRB Nestlé knows the remaining pipeline is too risky to acquire the whole company, it's likely to fail. MCRB was founded by Flagship Pioneering so be careful here, this may end up like $EVLO and $KLDO (failed Flagship Pioneering's microbiome companies).
0 · Reply
bdog_stayloyal
bdog_stayloyal Apr. 1 at 2:45 PM
$EVLO I will be very happy if I see this hit $0.07 today.
0 · Reply
sogenerous
sogenerous Feb. 26 at 3:49 PM
$MCRB I am watching this as a turnaround play $EVLO $KLDO went bankrupt in space they are last one left - I think this space has potential despite many setbacks. @Monkey_Banana_Genius Wonder if nestle buys them out, the amount of research in microbiome has exploded last 5 years . Might get 10k and leave it
1 · Reply
Tolon
Tolon Jan. 24 at 6:19 PM
$EVLO What will happen on the 26th to this company?
0 · Reply
Bat_shtt_crazy
Bat_shtt_crazy Dec. 28 at 5:54 PM
$EVLO Hey shortie smile for the camera
0 · Reply
Aamadmi
Aamadmi Dec. 21 at 4:29 PM
$EVLO $MCOM $SMFL Looks like Miami is stubborn in SMFL. Volume in all three can bring good Christmas. SMFL volume is insane
0 · Reply
Aamadmi
Aamadmi Dec. 21 at 3:59 PM
$EVLO Before anything else we need message volume between now and Jan 26th. Go EVLO. Wake up 1895 Watchers
0 · Reply
Aamadmi
Aamadmi Dec. 21 at 3:45 PM
$EVLO $SMFL $MCOM are choice of the day. Is Christmas here already? Good Luck. Share your thoughts as well. as always do your math and DD
0 · Reply
Aamadmi
Aamadmi Dec. 21 at 2:44 PM
$EVLO Trading pattern suggest Work in progress. Year end, Tax adjustments, Not sure how short covering work in dissolution, Just ride and stay ready to get off in time. Huge risk but big players are owning the stock most.... Could be diffrent now. Good luck do your DD before any action. Vote I believe is in late Jan
0 · Reply
Aamadmi
Aamadmi Dec. 19 at 7:54 PM
$EVLO Question is how high it can go before. We know bottom is 00. 52-Wk Range is 0.028 - 37.20. Taking my chances. Do your DD before you take dive before Institutional players. Who is first. Risky play
0 · Reply
Aamadmi
Aamadmi Dec. 19 at 7:50 PM
$EVLO Based on OTC market filing voting is supposed to be held on 26th Jan 2024. Lot of time to recover back lost ground by such high 83% Institutional Investor. See how far this has come down in 6 months. With dissolution in play. Some ground has to be covered which could be huge % gain, Question is when you enter or Entered. But do your math and DD prior to investing or any action. Risk Reward
0 · Reply